Evome Medical Technologies, Inc. Net Income
Evome Medical Technologies, Inc. reported Net Income of -CAD 15.60 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2024-04-16
- Evome Medical Technologies, Inc. net income (loss) attributable to parent for the quarter ending 2023-12-31 was -15.81M CAD.
- Evome Medical Technologies, Inc. net income (loss) attributable to parent for the quarter ending 2023-09-30 was 2.99M CAD.
- Evome Medical Technologies, Inc. net income (loss) attributable to parent for the quarter ending 2023-06-30 was -1.12M CAD.
- Evome Medical Technologies, Inc. net income (loss) attributable to parent for the quarter ending 2023-03-31 was -1.66M CAD.
- Evome Medical Technologies, Inc. net income (loss) attributable to parent for fiscal 2023 was -15.60M CAD.
- Evome Medical Technologies, Inc. net income (loss) attributable to parent for fiscal 2022 was -4.37M CAD.
- Evome Medical Technologies, Inc. net income (loss) attributable to parent for fiscal 2021 was -2.67M CAD.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 10 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | -15.81M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -12.82M CAD derived: sum of 2 quarters · filed 2024-04-16 | -13.94M CAD derived: sum of 3 quarters · filed 2024-04-16 | -15.60M CAD 10-K · filed 2024-04-16 | |
| 2023-09-30 | 2.99M CAD 10-Q · filed 2023-11-14 | 1.87M CAD derived: sum of 2 quarters · filed 2023-11-14 | 209.88K CAD 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | -1.12M CAD 10-Q · filed 2023-08-14 | -2.78M CAD 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | -1.66M CAD 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | -15.90M CAD 10-K · filed 2024-04-16 | ||||
| 2022-11-30 | -1.53M CAD 10-Q · filed 2023-01-17 | -14.33M CAD 10-Q · filed 2023-01-17 | |||
| 2022-09-30 | -9.80M CAD 10-Q · filed 2023-11-14 | -14.05M CAD 10-Q · filed 2023-11-14 | |||
| 2022-08-31 | -9.63M CAD 10-Q · filed 2022-10-17 | -12.80M CAD 10-Q · filed 2022-10-17 | |||
| 2022-06-30 | -3.65M CAD 10-Q · filed 2023-08-14 | -4.24M CAD 10-Q · filed 2023-08-14 | |||
| 2022-05-31 | -3.17M CAD 10-Q · filed 2022-07-15 | ||||
| 2022-03-31 | -593.63K CAD 10-Q · filed 2023-05-15 | ||||
| 2022-02-28 | -1.15M CAD derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03 | -2.65M CAD derived: sum of 2 quarters · filed 2023-04-03 | -3.74M CAD derived: sum of 3 quarters · filed 2023-04-03 | -4.37M CAD 10-KT · filed 2023-04-03 | |
| 2021-12-31 | -4.16M CAD 10-KT · filed 2023-04-03 | ||||
| 2021-11-30 | -1.50M CAD 10-Q · filed 2023-01-17 | -2.59M CAD derived: sum of 2 quarters · filed 2023-01-17 | -3.22M CAD 10-Q · filed 2023-01-17 | -5.05M CAD derived: sum of 4 quarters · filed 2023-01-17 | |
| 2021-08-31 | -1.08M CAD 10-Q · filed 2022-10-17 | -1.72M CAD 10-Q · filed 2022-10-17 | -3.55M CAD derived: sum of 3 quarters · filed 2022-10-17 | -3.91M CAD derived: sum of 4 quarters · filed 2022-10-17 | |
| 2021-05-31 | -634.60K CAD 10-Q · filed 2022-07-15 | -2.46M CAD derived: sum of 2 quarters · filed 2022-07-15 | -2.83M CAD derived: sum of 3 quarters · filed 2022-07-15 | -3.11M CAD derived: sum of 4 quarters · filed 2022-07-15 | |
| 2021-02-28 | -1.83M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | -2.19M CAD derived: sum of 2 quarters · filed 2022-05-31 | -2.47M CAD derived: sum of 3 quarters · filed 2022-05-31 | -2.67M CAD 10-K · filed 2022-05-31 | |
| 2020-11-30 | -361.22K CAD 10-Q · filed 2022-01-14 | -642.41K CAD derived: sum of 2 quarters · filed 2022-01-14 | -837.25K CAD 10-Q · filed 2022-01-14 | ||
| 2020-08-31 | -281.18K CAD 10-Q · filed 2021-10-15 | -476.03K CAD 10-Q · filed 2021-10-15 | |||
| 2020-05-31 | -194.85K CAD 10-Q/A · filed 2021-08-02 |